First Trust Direct Indexing’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,428
| Closed | -$1.73M | – | 117 |
|
|
2024
Q3 | $1.73M | Buy |
33,428
+11,831
| +55% | +$612K | 0.09% | 228 |
|
|
2024
Q2 | $897K | Sell |
21,597
-723
| -3% | -$30K | 0.06% | 333 |
|
|
2024
Q1 | $1.21M | Buy |
22,320
+7,649
| +52% | +$415K | 0.09% | 254 |
|
|
2023
Q4 | $753K | Sell |
14,671
-3,371
| -19% | -$173K | 0.07% | 334 |
|
|
2023
Q3 | $1.05M | Sell |
18,042
-285
| -2% | -$16.5K | 0.12% | 186 |
|
|
2023
Q2 | $1.17M | Buy |
18,327
+3,209
| +21% | +$205K | 0.13% | 176 |
|
|
2023
Q1 | $1.05M | Sell |
15,118
-2,579
| -15% | -$179K | 0.12% | 195 |
|
|
2022
Q4 | $1.27M | Sell |
17,697
-1,401
| -7% | -$101K | 0.17% | 152 |
|
|
2022
Q3 | $1.36M | Buy |
19,098
+10
| +0.1% | +$711 | 0.2% | 123 |
|
|
2022
Q2 | $1.47M | Buy |
19,088
+1,894
| +11% | +$146K | 0.2% | 118 |
|
|
2022
Q1 | $1.26M | Buy |
17,194
+3,204
| +23% | +$234K | 0.15% | 165 |
|
|
2021
Q4 | $872K | Sell |
13,990
-435
| -3% | -$27.1K | 0.11% | 217 |
|
|
2021
Q3 | $854K | Buy |
14,425
+588
| +4% | +$34.8K | 0.12% | 210 |
|
|
2021
Q2 | $925K | Sell |
13,837
-2,176
| -14% | -$145K | 0.14% | 186 |
|
|
2021
Q1 | $1.01M | Buy |
16,013
+1,323
| +9% | +$83.5K | 0.27% | 92 |
|
|
2020
Q4 | $904K | Buy |
+14,690
| New | +$904K | 0.24% | 95 |
|